243 related articles for article (PubMed ID: 25471696)
1. Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.
Humphreys JH; van Nies JA; Chipping J; Marshall T; van der Helm-van Mil AH; Symmons DP; Verstappen SM
Arthritis Res Ther; 2014 Dec; 16(6):483. PubMed ID: 25471696
[TBL] [Abstract][Full Text] [Related]
2. Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
Ajeganova S; Humphreys JH; Verheul MK; van Steenbergen HW; van Nies JA; Hafström I; Svensson B; Huizinga TW; Trouw LA; Verstappen SM; van der Helm-van Mil AH
Ann Rheum Dis; 2016 Nov; 75(11):1924-1932. PubMed ID: 26757747
[TBL] [Abstract][Full Text] [Related]
3. Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.
Ursum J; Bos WH; van de Stadt RJ; Dijkmans BA; van Schaardenburg D
Arthritis Res Ther; 2009; 11(3):R75. PubMed ID: 19460147
[TBL] [Abstract][Full Text] [Related]
4. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.
Ursum J; Bos WH; van Dillen N; Dijkmans BA; van Schaardenburg D
Arthritis Res Ther; 2010; 12(1):R8. PubMed ID: 20064278
[TBL] [Abstract][Full Text] [Related]
5. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.
Mouterde G; Rincheval N; Lukas C; Daien C; Saraux A; Dieudé P; Morel J; Combe B
Arthritis Res Ther; 2019 Jun; 21(1):140. PubMed ID: 31171038
[TBL] [Abstract][Full Text] [Related]
7. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D
Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016
[TBL] [Abstract][Full Text] [Related]
8. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
9. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
10. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
11. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
[TBL] [Abstract][Full Text] [Related]
12. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.
Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
Arthritis Res Ther; 2019 Nov; 21(1):246. PubMed ID: 31753003
[TBL] [Abstract][Full Text] [Related]
13. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
Murphy D; Mattey D; Hutchinson D
PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.
Gottenberg JE; Courvoisier DS; Hernandez MV; Iannone F; Lie E; Canhão H; Pavelka K; Hetland ML; Turesson C; Mariette X; Finckh A
Arthritis Rheumatol; 2016 Jun; 68(6):1346-52. PubMed ID: 26815727
[TBL] [Abstract][Full Text] [Related]
15. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
Mjaavatten MD; van der Heijde DM; Uhlig T; Haugen AJ; Nygaard H; Bjørneboe O; Kvien TK
J Rheumatol; 2011 Nov; 38(11):2336-41. PubMed ID: 21965645
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.
Brink M; Hansson M; Mathsson-Alm L; Wijayatunga P; Verheul MK; Trouw LA; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
Arthritis Res Ther; 2016 Feb; 18():43. PubMed ID: 26860413
[TBL] [Abstract][Full Text] [Related]
17. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
[TBL] [Abstract][Full Text] [Related]
18. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
[TBL] [Abstract][Full Text] [Related]
19. Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease-Modifying Antirheumatic Drugs: Results From a Real-World Study.
Alemao E; Bao Y; Weinblatt ME; Shadick N
Arthritis Care Res (Hoboken); 2020 Feb; 72(2):176-183. PubMed ID: 31529682
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.
Boeters DM; Mangnus L; Ajeganova S; Lindqvist E; Svensson B; Toes REM; Trouw LA; Huizinga TWJ; Berenbaum F; Morel J; Rantapää-Dahlqvist S; van der Helm-van Mil AHM
Arthritis Res Ther; 2017 May; 19(1):115. PubMed ID: 28569212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
